Innovative new model predicts glucose levels without poking or prodding
Abstract With the prevalence of type II diabetes rising rapidly it has become increasingly apparent that something must be done to stem the tide. While pharmaceutical treatments aimed at lowering average blood sugar are an important tool in this endeavor, it is equally (if not more) important to mot...
Enregistré dans:
Auteurs principaux: | Leia Wedlund, Joseph Kvedar |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/07654ed2e5cf4b4f8f99ed205e978bd6 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
New machine learning model predicts who may benefit most from COVID-19 vaccination
par: Leia Wedlund, et autres
Publié: (2021) -
Simulated trials: in silico approach adds depth and nuance to the RCT gold-standard
par: Leia Wedlund, et autres
Publié: (2021) -
Wearables as a tool for measuring therapeutic adherence in behavioral health
par: Leia Wedlund, et autres
Publié: (2021) -
Anticipating and treating dementia: lessons hidden in plain sight
par: Leia Wedlund, et autres
Publié: (2020) -
Beyond performance metrics: modeling outcomes and cost for clinical machine learning
par: James A. Diao, et autres
Publié: (2021)